• Zepatier yields high SVR12 in real-world VA cohort

    2 days ago - By Healio

    AMSTERDAM - Zepatier was associated with SVR12 rates above 95% in a real-world, Veterans Affairs cohort, according to data presented at the International Liver Congress. Amy Puenpatom , MD, of the center for observational and real-world evidence at Merck Sharp & Dohme Corp., said that the current study is the largest study of Zepatier to date. The current retrospective database analysis included patients from Feb. 1, 2016, through Aug. 1, 2016. There were 2,436 patients in an evaluable population and 2,257 patients in a per-protocol population. Puenpatom focused her comments on the...
    Read more ...